Mustang Bio, Inc.
MBIO
$0.74
$0.045.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 74.58% | 87.80% | 90.03% | 89.78% | 73.28% |
| Total Depreciation and Amortization | -100.00% | -95.02% | -89.56% | -88.30% | -91.86% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -290.67% | -236.17% | -150.58% | -193.72% | -67.41% |
| Change in Net Operating Assets | -124.54% | -155.95% | -162.93% | -189.79% | 245.45% |
| Cash from Operations | 34.70% | 53.87% | 66.74% | 75.93% | 79.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -80.58% | -80.58% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | -- | 3,983.33% | -80.32% | -80.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -62.06% | 31.03% | 83.62% | 36.12% | 293.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.31% | 28.95% | 89.23% | 40.02% | 172.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -83.81% | 7,291.03% | 335.25% | 169.74% | 121.91% |